AML (ACUTE MYELOID LEUKEMIA)
Clinical trials for AML (ACUTE MYELOID LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOID LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOID LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New stem cell combo could boost survival in blood cancer patients
Disease control Recruiting nowThis study is testing a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It combines stem cells from a half-matched donor (haploidentical) with cord blood, given at different times. The goal is to help …
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New hope for blood cancer patients: daily pill aims to prevent relapse without transplant
Disease control Recruiting nowThis study tests a daily pill called ivosidenib in about 20 adults with a specific genetic form of acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) who cannot receive a stem cell transplant. The goal is to see if the drug can keep the cancer from coming ba…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goals are to check safety and see if it can prevent the cancer from coming …
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug cocktail shows promise for untreated leukemia patients
Disease control Recruiting nowThis study tests a combination of five drugs (venetoclax, azacitidine, cytarabine, idarubicin, and G-CSF) as a first treatment for adults aged 18-70 with acute myeloid leukemia (AML) who are healthy enough for strong chemotherapy. The goal is to see how many patients achieve comp…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for Hard-to-Treat blood cancers? early trial of CBX-250 begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called CBX-250 in people with certain blood cancers (like acute myeloid leukemia) that have come back or not responded to standard treatments. The main goals are to check the drug's safety and find the best dose. About 72 participants …
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New pill aims to keep leukemia away after transplant
Disease control Recruiting nowThis phase II trial tests whether the drug chidamide can help prevent acute myeloid leukemia (AML) from coming back after a stem cell transplant. About 134 adults with high-risk AML who are in remission after transplant will either take chidamide pills or receive standard observa…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New study checks if cancer drug olutasidenib changes how other medicines work
Knowledge-focused Recruiting nowThis study looks at how the cancer drug olutasidenib affects the way the body processes other medications. Researchers will give 16 adults with IDH1-mutated cancers a mix of test drugs before and during olutasidenib treatment to measure changes in drug levels. The goal is to ensu…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Smartwatches could help doctors personalize blood transfusions for cancer patients
Knowledge-focused Recruiting nowThis study is for 80 adults with blood cancers like MDS or AML who are starting treatment. Participants wear a smartwatch and answer questionnaires to track their activity, symptoms, and quality of life. The goal is to help doctors better understand when patients need blood trans…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Mouse avatars could speed up AML treatment discovery
Knowledge-focused Recruiting nowThis study aims to develop a faster way to test new drug combinations for acute myeloid leukemia (AML). Researchers will take blood and bone marrow samples from 25 adults with AML and grow their cancer cells in special mice. They will then test how well standard treatments work i…
Matched conditions: AML (ACUTE MYELOID LEUKEMIA)
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC